AB International Health Care Portfolio Fund(LU0097089360)
- Equities
- Healthcare
- Global
- USD Cash
- Accumulating
The Fund seeks capital growth by investing primarily in equity securities of health care and health care-related companies located throughout the world, employing rigorous bottom-up research to identify companies with long-term growth potential in va...
Maintains a high-conviction, quality-focused portfolio investing primarily in global equity securities within the healthcare and healthcare-related sectors. Provides concentrated exposure to a diversified range of sub-sectors, including biotechnology, pharmaceuticals, and healthcare equipment and services. Typically holds between 40 to 60 positions to ensure targeted exposure while maintaining prudent diversification within the sector.
Led by a lead portfolio manager with over 20 years of specialized experience in healthcare investing. Supported by a co-portfolio manager and senior research analyst who brings two decades of industry expertise to the strategy. The broader investment team consists of specialized healthcare analysts with an average of nearly 20 years of professional experience.
Leverages a structural quality tilt designed to provide resilience during periods of market volatility and heightened focus on fundamentals. Aims to deliver superior risk-adjusted returns over a full market cycle compared to specialized peer strategies. Performance may experience temporary headwinds during momentum-driven market regimes where fundamental quality is less rewarded. Employs strict risk management protocols, including limits on individual stock contributions to tracking error, to manage overall portfolio volatility.
Utilizes a rigorous bottom-up research framework to identify companies displaying sustainable long-term growth and high-quality characteristics. Focuses on fundamental metrics such as strong cash flow generation, high return on capital, and clear strategic research and development objectives. Integrates Environmental, Social, and Governance (ESG) factors by evaluating sector-specific risks, including patient data security and waste management. Maintains a disciplined approach to portfolio construction by balancing high-conviction ideas with sub-sector and geographical diversification.
Access to institutional share class with no trailer fees to achieve the lowest possible fees
Serves as a specialized satellite allocation for investors seeking high-quality exposure to the global healthcare sector. Provides a thematic component to a broader portfolio, capturing secular growth trends across various healthcare sub-industries. Should be used in conjunction with a core diversified portfolio to mitigate the concentration risks inherent in sector-specific investing.
Daily data. Returns as of 16 Sep 2026.
| Year | Total | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2026 | - | 0.8% | 3.2% | -7.9% | -0.4% | 2.0% | 4.5% | 1.5% | 4.0% | - | - | - | - |
| 2025 | 10.6% | 5.2% | 1.1% | -2.3% | -1.8% | -4.2% | 1.2% | -4.1% | 3.9% | 2.2% | 2.5% | 7.9% | -0.9% |
| 2024 | -1.7% | 2.4% | 2.9% | 2.2% | -5.2% | 3.5% | 2.6% | 1.2% | 5.8% | -4.1% | -5.1% | -0.1% | -6.9% |
| 2023 | 10.2% | 1.0% | -3.6% | 3.7% | 3.2% | -3.5% | 2.4% | 1.7% | 0.5% | -2.8% | -2.5% | 5.4% | 4.7% |
| 2022 | -9.6% | -8.8% | -0.4% | 4.1% | -5.4% | -1.6% | -2.3% | 4.4% | -6.3% | -4.4% | 9.0% | 6.3% | -3.0% |
| Load more | 5 of 28 | ||||||||||||
| Johnson & Johnson | 9.49% |
| Eli Lilly and Co | 9.15% |
| UnitedHealth Group Inc | 6.56% |
| Merck & Co Inc | 6.08% |
| Roche Holding AG Ordinary Shares new | 5.42% |
| Novartis AG Registered Shares | 4.49% |
| Vertex Pharmaceuticals Inc | 3.82% |
| AstraZeneca PLC | 3.72% |
| Gilead Sciences Inc | 3.55% |
| Edwards Lifesciences Corp | 3.29% |
Disclaimer: ©2025 Morningstar. All Rights Reserved. The information contained here relating to a particular collective investment scheme: (1) is proprietary to Morningstar Research Pte. Limited and/or its content providers (“Information Provider(s)“) unless otherwise specified; and (2) may not be copied or distributed. Neither the Information Provider nor Endowus guarantee or endorse the accuracy, reliability, completeness or timeliness of the information, or are responsible for any damages or losses arising from any use of this information. Further, for technical reasons, certain information provided by Information Provider may be different from that supplied by the respective fund houses.
This website is for information purposes only and is not and should not be construed as an offer or the solicitation of an offer or a recommendation for the purchase or sale of any investment or subscribe for, or to participate in, any services. Any opinion or estimate above is made on a general basis and none of Endowus, nor any of its affiliates, representatives, or agents have given any consideration to nor have made any investigation of the objective, financial situation, or particular need of any user, reader, any specific person or group of persons. Opinions expressed herein are subject to change without notice. You should carefully consider whether any investment views and investment products/services are appropriate in view of your investment experience, objectives, financial resources and relevant circumstances or seek financial advice via Endowus' platform.
Investment involves risk. The value of investments and the income from them can go down as well as up, and you may not get the full amount you invested. Past performance is not an indicator nor a guarantee of future performance. Rates of exchange may cause the value of investments to go up or down. Individual stock performance does not represent the return of a fund.
You are responsible for downloads from this website. Endowus does not warrant that any downloads from this website will meet your needs or expectations, or be uninterrupted, secure, or error free or that any files available for downloading through this website are free of computer viruses or other harmful components. You alone are responsible for ensuring adequate protection and backup of data, software, computer, and other equipment is made and appropriate safeguard is in place to detect, prevent and eliminate computer viruses and other harmful effects. Neither Endowus nor the Information Provider will be responsible for any costs or expenses which may be incurred if your use of this website or if any downloads results in any servicing or replacement of property, material, equipment, or data.
This advertisement has not been reviewed by the Monetary Authority of Singapore.